METTL3 and major depressive disorder: Similarly, human postmortem brain studies have shown that reduced FTO expression in the hippocampus [67], as well as reduced FTO expression and increased METTL3 expression in the dorsolateral prefrontal cortex (dlPFC) [68], are associated with MDD.